An observational study in Periodontal Disease and Diabete Mellitus, sponsored by University of Roma La Sapienza. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-28.
Sponsored by University of Roma La Sapienza · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies in Periodontal Diseases with a site in Italy — 18 open to participants now, 20 under way, none of them phase 3. Periodontal Diseases · Italy.
Among the 72 studies in Periodontal Diseases with a site in Italy, this one is the 17th largest by planned enrollment of the 24 observational ones that give a count, is one of 7 that started in 2026, is one of 24 observational ones, reaches primary completion later than 15 of the 19 other live ones, and was the 69th registered.
871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.
Browse Periodontal Diseases studies →18 of the 72 studies in Periodontal Diseases with a site in Italy are open now. Recruiting first, the newest first:
University of Turin, Italy · Sites in Italy
Ages 18–60
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Sites in Italy, China, United Kingdom
Ages 18+ · Healthy volunteers
University of Bologna · Sites in Italy
Ages 18+ · Healthy volunteers
University of Pavia · Sites in Italy
Ages 18–45 · Women only
University of Pavia · Sites in Italy
Ages 18+ · Women only
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 7 started in 2026.
This study's planned enrollment of 100 is close to the median of 100 across 304 observational studies indexed under Periodontal Diseases.
Median enrollment 40 across the 48 interventional studies, 126 across the 24 observational. Of the 45 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 72 have an industry lead sponsor. The 10 most frequent:
University of Roma La Sapienza is the lead sponsor of 398 studies on the registry; 56 are open to participants now.
University of Roma La Sapienza has 4 studies filed under Periodontal Diseases — fewer than ten, so there is no comparison to draw.
3 of the studies in Periodontal Diseases with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07604493University of Roma La SapienzaOral Health and Systemic Diseases: Survey of General Practitioners | 2026-11-30 |
| NCT07725913University of BolognaThermosensitive Hyaluronic Gel With Octenidine as an Adjunctive to Subgingival Instrumentation | 2027-02-01 |
| NCT07905859University of Turin, ItalyEffects Of Periodontal Therapy In Patients With Inflammatory Bowel Disease | 2027-09-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 72 studies in Periodontal Diseases with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This cross-sectional observational study aims to assess the level of knowledge, clinical practices, and professional attitudes of General Practitioners (GPs) regarding oral health and its relationship with major systemic diseases, with particular emphasis on periodontal disease. Data will be collected through an anonymous, self-administered digital questionnaire distributed nationwide to General Practitioners practicing in Italy. The questionnaire will investigate participants' knowledge of oral diseases, awareness of oral-systemic associations, early identification of oral manifestations, educational background, and interdisciplinary collaboration with dental professionals.
The aim of this study is to conduct an exploratory survey designed to assess the level of knowledge among General Practitioners (GPs) regarding the main diseases of the oral cavity, particularly dental caries and periodontal diseases, and their associations with systemic conditions, with special attention to autoimmune, dysmetabolic, and cardiovascular diseases.
To achieve this objective, an anonymous questionnaire consisting of 35 questions has been developed, with an estimated completion time of approximately 10-15 minutes. The questionnaire is intended to investigate participants' familiarity with terminology related to periodontal disease, particularly the terms "periodontitis" and "pyorrhea," which are used to describe the same clinical condition, as well as their level of knowledge regarding its manifestations and clinical implications.
The survey will further investigate General Practitioners' ability to recognize oral signs and symptoms potentially associated with local or systemic diseases, as well as the frequency with which these aspects are considered in routine clinical practice and patient assessment. Information will also be collected regarding previous education and training in oral health-related fields and knowledge of major risk factors associated with oral diseases, including smoking, diabetes mellitus, and medications with significant oral health impact.
Analysis of the collected data will provide insight into the extent to which oral health is integrated into general medical practice, highlighting potential educational gaps and challenges in the early recognition of oral alterations. In addition, the study will assess participants' interest in specific educational and continuing professional development initiatives.
The expected findings may contribute to strengthening collaboration between general medicine and dentistry by promoting shared approaches to prevention, screening, and education aimed at achieving a more comprehensive and integrated management of patients, particularly vulnerable populations. Furthermore, the information obtained may provide useful support for the development of preventive strategies and clinical protocols aimed at improving multidisciplinary patient care.
The study population will consist of General Practitioners (GPs) currently practicing in Italy. Participants will voluntarily participate after receiving study information and providing informed consent. Eligible participants will complete an anonymous self-administered digital questionnaire designed to assess their knowledge, clinical practices, and professional attitudes regarding oral health and its associations with systemic diseases.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
General Practictioners currently practicing in Italy
Other: Questionnaire Survey
Participants will complete a questionnaire consisting of 35 closed-ended questions designed to assess General Practitioners' knowledge, clinical practices, and attitudes regarding oral health and its relationship with systemic diseases.
General Practitioners' level of knowledge regarding oral diseases and oral-systemic associations
Knowledge level will be assessed through a predefined set of questionnaire items investigating participants' understanding of: * Common oral diseases * Periodontal disease * Associations between oral and systemic diseases * Risk factors and preventive measures The total knowledge score will be calculated by summing the number of correct responses provided by each participant. Higher total scores will indicate a greater level of knowledge among General Practitioners regarding oral diseases, periodontal disease, oral-systemic associations, risk factors, and oral health-related clinical practices. Scores may additionally be categorized for descriptive analysis as: * Low level of knowledge: \<50% correct responses * Moderate level of knowledge: 50-75% correct responses * High level of knowledge: \>75% correct responses
Time frame: At questionnaire completion (at baseline)
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Nov 2026, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Roma La Sapienza →